Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
1 Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
2 Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
3 Fudan University Cancer Center, Shanghai, China.
4 Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
5 Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
6 Jiangxi Cancer Hospital, Nanchang, China.
7 Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China.
8 Guizhou Cancer Hospital of Guizhou Medical University, Guiyang, China.
9 Shenzhen People's Hospital, Shenzhen, China.
10 Fujian Provincial Cancer Hospital, Fuzhou, China.
11 The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
12 West China Hospital of Sichuan University, Chengdu, China.
13 The Second Xiangya Hospital of Central South University, Changsha, China.
14 Taichung Veterans General Hospital, Taichung, Taiwan.
15 Cancer Hospital of Shantou University Medical College, Shantou, China.
16 Jiangsu Cancer Hospital, Nanjing, China.
17 Chang Gung Memorial Hospital, Taoyuan, Taiwan.
18 National Cancer Centre, Singapore City, Singapore.
19 Nanfang Hospital, Guangzhou, China.
20 Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
21 Zhejiang Cancer Hospital, Hangzhou, China.
22 The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
23 Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
24 Shanghai General Hospital, Shanghai, China.
25 Fujian Medical University Union Hospital, Fuzhou, China.
26 The Fourth Hospital of Hebei Medical University Hebei Cancer Hospital, Shijiazhuang, China.
27 Hainan General Hospital, Haikou, China.
28 Liuzhou Worker's Hospital, Liuzhou, China.
29 China Medical University Hospital, Taichung, Taiwan.
30 Taipei Veterans General Hospital, Taipei, Taiwan.
31 National Cheng Kung University, Tainan, Taiwan.
32 Tan Tock Seng Hospital, Singapore City, Singapore.
33 Johns Hopkins University, Baltimore, MD, USA.
34 Shanghai Junshi Biosciences, Shanghai, China.
35 TopAlliance Biosciences, Rockville, MD, USA.
36 Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. xurh@sysucc.org.cn.